Liver mass evaluation: Difference between revisions
No edit summary |
|||
Line 8: | Line 8: | ||
==Liver Mass Evaluation== | ==Liver Mass Evaluation== | ||
*The algorithm below summarizes the initial liver mass evaluation | *The algorithm below summarizes the initial liver mass evaluation | ||
{{Familytree/start}} | |||
{{Familytree | | | | | | | A01 | | | | | | A01= <div style="float: left; text-align:center; width: 15em; padding:1em;">'''Liver mass detected'''<br><SMALL> Adapted from Bonder et al.</SMALL></div>}} | |||
{{Familytree | | | | | | | |!| | | | | | | }} | |||
{{Familytree | | | | | | | A02 | | | | | | A02= <div style="float: left; text-align:center; width: 15em; padding:1em;">'''Relevant medical history to obtain:'''</div>}} | |||
{{Familytree | | | | | | | A03 | | | | | | A03= <div style="float: left; text-align:left; width: 15em; padding:1em;"> ❑ Age and gender <br> ❑ Symptoms: jaundice, pain, nausea<br> ❑ Recent travel <br> ❑ Hepatitis serology<br> ❑ Iron studies<br> ❑ Use of oral contraceptives <br>❑ AFP levels <br>❑ From endemic area of hepatitis <br> ❑ History of chronic liver disease <br>❑ Physical findings</div>}} | |||
{{Familytree | | | |,|-|-|-|^|-|-|-|.| | | }} | |||
{{Familytree | | | B01 | | | | | | B02 | | | B01=<div style="float: left; text-align:center; width: 15em; padding:1em;">'''Chronic liver disease<br> Hepatitis B or C'''</div> | |||
|B02=<div style="float: left; text-align:center; width: 15em; padding:1em;"> '''No history of chronic liver disease'''</div>}} | |||
{{Familytree | | | |!| | | | | | | |!| | | | |}} | |||
{{Familytree | | | |!| | | | | | | |!| | | | |}} | |||
{{Familytree | | | |!| | | | | | | |!| | | | |}} | |||
{{Familytree | | | |!| | | | | | | |!| | | | |}} | |||
{{Familytree | | | C01 | | | | | | X02 | |C01=<div style="float: left; text-align:center; width: 15em; padding:1em;">'''Check AFP, triphasic CT or MRI''' <br> Follow-up screening guidelines as cirrhotic patient</div>|X02=<div style="float: left; text-align:center; width: 15em; padding:1em;"> '''Benign characteristics of a liver mass'''<br>Follow-up accordingly</div>}}}} | |||
{{Familytree/end}} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 18:38, 25 March 2016
Liver Mass Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liver mass evaluation On the Web |
American Roentgen Ray Society Images of Liver mass evaluation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
A hallmark feature in the evaluation of liver mass is the malignancy assessment. The evaluation approach of liver mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, imaging pattern, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of liver mass. Lung mass can be divided into 2 categories: benign liver mass and malignant liver mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.
Liver Mass Evaluation
- The algorithm below summarizes the initial liver mass evaluation
Liver mass detected Adapted from Bonder et al. | |||||||||||||||||||||||||||||||||
Relevant medical history to obtain: | |||||||||||||||||||||||||||||||||
❑ Age and gender ❑ Symptoms: jaundice, pain, nausea ❑ Recent travel ❑ Hepatitis serology ❑ Iron studies ❑ Use of oral contraceptives ❑ AFP levels ❑ From endemic area of hepatitis ❑ History of chronic liver disease ❑ Physical findings | |||||||||||||||||||||||||||||||||
Chronic liver disease Hepatitis B or C | No history of chronic liver disease | ||||||||||||||||||||||||||||||||
Check AFP, triphasic CT or MRI Follow-up screening guidelines as cirrhotic patient | Benign characteristics of a liver mass Follow-up accordingly | ||||||||||||||||||||||||||||||||